FMR LLC 13D and 13G filings for Sage Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Sale | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 4,117,006 6.700% | -1,154,102 (-21.89%) | Filing |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 5,271,108 8.634% | -1,031,366 (-16.36%) | Filing |
| 2024-06-10 09:48 am Purchase | 2024-06-07 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 6,302,474 10.472% | 819,997 (+14.96%) | Filing |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 5,482,477 9.132% | -1,069,013 (-16.32%) | Filing |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 6,551,490 11.012% | 574,397 (+9.61%) | Filing |
| 2022-07-11 08:49 am Purchase | 2022-07-08 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 5,977,093 10.119% | 486,519 (+8.86%) | Filing |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 5,490,574 9.320% | -188,697 (-3.32%) | Filing |
| 2021-08-10 10:33 am Sale | 2021-08-09 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 5,679,271 9.711% | -2,127,428 (-27.25%) | Filing |
| 2021-02-08 10:31 am Purchase | 2021-02-05 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 7,806,699 14.999% | 34,070 (+0.44%) | Filing |